FMP-Transfer/Projekte

Most recent technology transfer projects

Funding authority	Programme	Title	Period
SPRIN-D	Ein Quantensprung für neue antivirale Wirkstoffe	MucBoost (D. Lauster, B. Kaufer, J. Trimpert/FU Berlin, Chr. Hackenberger/FMP, Chr. Sieben/HZI, P. Boisguerin/Inserm, and M. Hittinger/PharmBioTec)	11.2021 - 10.2023
Leibniz Association	Leibniz-Transfer	Selective depletion of plasma cells secreting pathogenic autoantibodies in chronic autoimmune diseases - a potentially curative therapeutic approach (F. Hiepe/Charité & DRFZ, A. Meisel/Charité, Chr. Hackenberger/FMP)	01.2021 - 12.2023
Crowdfunding	www.gofundme.com	Development of an enzyme replacement therapy for the treatment of transglutaminase-1-deficient autosomal recessive congenital ichthyosis (M. Dathe/FMP and H. Traupe/WWU)	Ongoing
Leibniz Association	Leibniz-Transfer	Cystein‐selective bioconjugation for next generation antibody drug conjugates (Chr. Hackenberger/FMP)	03.2018 - 12.2022
Federal Ministry of Education and Research (BMBF)	Targetvalidierung für die pharmazeutische Wirkstoffentwicklung	Evaluating Ena/VASP as a novel relevant drug target for treatment of cancer metastasis (R. Kühne/FMP and H.-G. Schmalz/University of Cologne)	01.2018 - 04.2020
Bavarian Ministry of Economic Affairs and Media, Energy and Technology	m4 Award	Development of a Tubulis Technologies proprietary ADC for Acute Myeloid Leukemia treatment (Jonas Helma-Smets, Dominik Schumacher, Heinrich Leonhardt/LMU and Christian Hackenberger/FMP)	01.2018 - 12.2019
Federal Ministry for Economic Affairs and Energy (BMWi)	EXIST Forschungstransfer I	Tubulis Technologies, a pre-start-up project affiliated with the Ludwig Maximilians University Munich (LMU, Jonas Helma-Smets, Dominik Schumacher, Heinrich Leonhardt) and the FMP (Christian Hackenberger)	04.2017 - 09.2019